Canon Inc. (CAJ)


NYSE - NYSE Real Time Price. Currency in USD
28.90-0.39 (-1.33%)
At close: 4:02 PM EDT
People also watch:
DCMKYONTTHMCNMR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open28.95
Prev Close29.29
Bid28.89 x 700
Ask28.90 x 700
Day's Range28.86 - 28.98
52wk Range26.60 - 31.96
1y Target EstN/A
Market Cap31.56B
P/E Ratio (ttm)16.06
Beta0.66
Volume130,844
Avg Vol (3m)271,382
Dividend & Yield1.41 (4.88%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Market Realist2 days ago

    GoPro Rises after Its KARMA and HERO5 Product Launches

    GoPro (GPRO) continued its rise on September 22, 2016, after it launched its KARMA drone and a new HERO5 camera.

  • Market Realist2 days ago

    Canon Announces Its New Investment Plans

    Canon (CAJ) reported 2Q16 net sales of 860.2 billion Japanese yen (about $8.4 billion), which represents a fall of 11.7% from its net sales of 974.4 billion yen (about $9.5 billion) in 2Q15.

  • American City Business Journals2 days ago

    Canon acquires 20% stake in Lexington diagnostics firm

    Shares of Lexington-based T2 Biosystems have spiked 18 percent on the news that a Japanese corporation best known for making cameras, Canon, is now a 20 percent owner. Canon U.S.A. (CAJ) is moving further into the medical device space with a $40 million private placement, for $6.56 a share, in T2 Biosystems (TTOO). The latest camera-maker to invest in the medical device space — Olympus has also expanded into laproscopic scopes and imaging devices — Canon "continues to build a significant medical diagnostics franchise,” said T2 CEO John McDonough.